Kimia Biosciences
33.80
+0.27(+0.81%)
Market Cap₹158.60 Cr
PE Ratio18.19
IndustryHealthcare
Company Performance:
1D+0.81%
1M-5.35%
6M-17.54%
1Y-33.06%
5Y+9.39%
View Company Insightsright
Latest news about Kimia Biosciences
Kimia Biosciences Reports Mixed Q1 FY2026 Results with Sequential Growth Aug 16, 2025
Kimia Biosciences Limited released unaudited standalone financial results for Q1 FY2026 ended June 30, 2025. Total income was ₹6,103.00 lakhs (-1.61% YoY, +20.18% QoQ), net profit ₹613.00 lakhs (-1.13% YoY, +6.06% QoQ), and EPS ₹4.31 (-2.05% YoY, +6.42% QoQ). The company showed resilience with significant sequential growth despite slight year-over-year declines. Results were published in English and Hindi newspapers for regulatory compliance.
Kimia Biosciences Approves Q1 Results, Appoints New CFO, and Raises ₹2 Crore Loan Aug 14, 2025